GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Operating Margin %

Labiana Health (XMAD:LAB) Operating Margin % : -8.77% (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Labiana Health's Operating Income for the six months ended in Dec. 2022 was €-2.53 Mil. Labiana Health's Revenue for the six months ended in Dec. 2022 was €28.79 Mil. Therefore, Labiana Health's Operating Margin % for the quarter that ended in Dec. 2022 was -8.77%.

The historical rank and industry rank for Labiana Health's Operating Margin % or its related term are showing as below:


XMAD:LAB's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.21
* Ranked among companies with meaningful Operating Margin % only.

Labiana Health's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Labiana Health's Operating Income for the six months ended in Dec. 2022 was €-2.53 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2022 was €-2.38 Mil.


Labiana Health Operating Margin % Historical Data

The historical data trend for Labiana Health's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Operating Margin % Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Operating Margin %
4.34 1.15 -4.11

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Operating Margin % - - 0.50 -8.77

Competitive Comparison of Labiana Health's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Labiana Health's Operating Margin % falls into.



Labiana Health Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Labiana Health's Operating Margin % for the fiscal year that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-2.38 / 57.848
=-4.11 %

Labiana Health's Operating Margin % for the quarter that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=-2.525 / 28.787
=-8.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health  (XMAD:LAB) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Labiana Health Operating Margin % Related Terms

Thank you for viewing the detailed overview of Labiana Health's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.